EIF2AK3 and cardiac arrhythmia: Liu et al.138 found that both genetic and pharmacological inhibition of PERK shortened Q and T waves on ECGs (thus shortening QTc intervals), decreased ventricular tachycardia episodes, and heightened survival rates after MI, suggesting that inhibiting PERK may reduce arrhythmia risk after MI.